ZARZIO

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug ZARZIO contains one active pharmaceutical ingredient (API):

1 Filgrastim UNII PVI5M0M1GW - FILGRASTIM

Filgrastim causes marked increases in peripheral blood neutrophil counts within 24 hours, with minor increases in monocytes. Read about Filgrastim

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZARZIO Solution for injection / infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L03AA02	Filgrastim	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AA Colony stimulating factors
Discover more medicines within L03AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2733W, 2747N, 2758E, 2783L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 511518120069307
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 10271504, 10275956, 11013342, 11013359, 11138569, 11138575, 11218854, 11218860, 11367778, 11367784, 11657625, 11852999, 11856655, 11856661, 11878378, 12345460, 12366522, 12388251, 12536243, 12536266, 12554459, 12562499, 12562507, 12566936, 12566942, 12802785, 12802816, 12871622, 12871639, 14178233, 14417608, 15390113, 15390136, 15433762, 15433779, 16744027, 16744033, 17180420
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 68-MBE-0816, 85-MBE-0117
Country: EE	Ravimiamet	Identifier(s): 1399204, 1399215, 1399226, 1399237, 1399248, 1399259, 1399260, 1399271
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 08495001, 08495003, 08495005, 08495007
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 157756, 170672
Country: FR	Base de données publique des médicaments	Identifier(s): 60514839, 60670037
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 199531, 199533
Country: HK	Department of Health Drug Office	Identifier(s): 62169, 64300
Country: IT	Agenzia del Farmaco	Identifier(s): 039125012, 039125024, 039125036, 039125048, 039125051, 039125063, 039125075, 039125087
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1036013, 1036014, 1036015, 1036016, 1036017, 1036018, 1036019, 1036020, 1058043, 1058044, 1058045, 1058046, 1058047, 1058048, 1058049, 1058050
Country: NL	Z-Index G-Standaard	Identifier(s): 14165082
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 41831, 41858
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 14962, 14963
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100206431, 100206454
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W53892001, W53892002, W53892003, W53892004, W53893001, W53893002, W53893003, W53893004
Country: SG	Health Sciences Authority	Identifier(s): 14764P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 11073011H, 11073012H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681428951079, 8681428951086, 8681428951093, 8681428951109
Country: ZA	Health Products Regulatory Authority	Identifier(s): 47/30.4/0603, 47/30.4/0604